Fred Alger Management »

Ambrx Biopharma shares owned by Fred Alger Management

Quarter-by-quarter ownership of Ambrx Biopharma shares owned by Fred Alger Management from 13F filings

Historical chart of Fred Alger Management investment in Ambrx Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Ambrx Biopharma held by Fred Alger Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ambrx Biopharma by Fred Alger Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $468k 33k 14.24

More positions owned by Fred Alger Management

Microsoft Corp Common (MSFT)
Amazon Common (AMZN)
Apple Common (AAPL)
Nvidia Corp. Common (NVDA)
Meta Platforms Inc Class A Common (META)
Alphabet Inc Cl C Common (GOOG)
Natera Common (NTRA)
Visa Inc Class A Shares Common (V)
Mercadolibre Common (MELI)
Transdigm Group Common (TDG)
Adobe Common (ADBE)
Marvell Technology Group Common (MRVL)
Gfl Environmental Common (GFL)
Pinterest Inc Class A Common (PINS)
Advanced Micro Devices Common (AMD)

View all positions for Fred Alger Management

Top funds holding Ambrx Biopharma

Darwin Global Management
Cormorant Asset Management
Paradigm Biocapital Advisors
D. E. Shaw & Co
Nextech Invest
Balyasny Asset Management
Citadel Advisors
Logos Global Management
VR Adviser
Vanguard Group
T. Rowe Price Associates
Millennium Management
Goldman Sachs Group
Federated Investors
OrbiMed Advisors

View all funds holding Ambrx Biopharma